CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. David Meek bought Bluebird Bio last year ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx ...

AI giant Anthropic has already become a dominant player in technology and a household name for everyday users of artificial ...

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, ...

The Food and Drug Administration on Monday published the names of eight new panelists who will serve on a committee advising ...

Demand for alcohol is declining. The industry is fighting harder and more creatively than ever against limits — and winning.

Today's health tech news includes virtual PT for a whole country, what the FDA is considering on AI policy, and more ...